Related Experiment Videos
Effect of postoperative mydriatics on the iris
1Ophthalmology Department, Ninewells Hospital and Medical School, Dundee, Scotland.
Journal of Cataract and Refractive Surgery
|June 1, 1996
Summary
Postoperative mydriatics after cataract surgery did not reduce inflammation but increased iris-lens adhesions. Routine use of mydriatics is not recommended following extracapsular cataract extraction and intraocular lens implantation.
Area of Science:
- Ophthalmology
- Surgical Outcomes
Background:
- Cataract surgery, specifically extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens (IOL) implantation, is a common procedure.
- Postoperative management, including the use of mydriatics, aims to control inflammation and ensure proper healing.
Purpose of the Study:
- To evaluate the effect of postoperative mydriatics on iris modifications and inflammation after ECCE and IOL implantation.
- To determine if mydriatics influence the incidence of iris adhesions and anterior chamber inflammation.
Main Methods:
- A prospective study involving 136 patients undergoing standardized ECCE.
- Patients were divided into two groups: one receiving mydriatics postoperatively for two weeks, the other not.
- Evaluations included anterior chamber activity, pain, redness at two weeks, and pupil shape, synechias, IOL position, and iris adhesions at six weeks.
Main Results:
- Significantly higher rates of iris-lens adhesions were observed in the group treated with mydriatics.
- No statistically significant difference in the level of postoperative inflammation was found between the mydriatic and non-mydriatic groups.
Conclusions:
- Routine administration of mydriatics after ECCE with posterior chamber IOL implantation is not supported by these findings.
- The increased risk of iris-lens adhesions outweighs potential benefits, suggesting a need to reconsider mydriatic use in this context.